Table 3. Comparison of infection between the Chinese IDUs and the Burmese male IDUs.
| Parameter | HIV | HBV | HCV | ||||||
| Chinese IDUs | Burmese IDUs | P | Chinese IDUs | Burmese IDUs | P | Chinese IDUs | Burmese IDUs | P | |
| Age (Mean±SD) | 33.8±7.9 | 30.7±7.8 | <0.01 | 34.4±9.3 | 32.0±9.0 | <0.05 | 34.7±7.5 | 30.8±6.1 | <0.05 |
| Male Gendera | 134/399(33.6%) | 82/279(29.4%) | NS | 204/399(51.1%) | 123/279(44.1%) | NS | 275/399(68.9%) | 145/279(52.0%) | <0.001 |
| Ethnicity | |||||||||
| Hanb | 48/166(28.9%) | 18/82(22.0%) | NS | 76/166(45.8%) | 32/82(39.0%) | NS | 104/166(62.7%) | 31/82(37.8%) | <0.001 |
| Daic | 59/168(35.1%) | 8/44(18.2%) | <0.05 | 103/168(61.3%) | 19/44(43.2%) | <0.05 | 119/168(70.8%) | 21/44(47.7%) | <0.005 |
| Jingpod | 24/53(45.3%) | 41/138(29.7%) | <0.05 | 21/53(39.6%) | 57/138(41.3%) | NS | 41/53(77.4%) | 73/138(52.9%) | <0.005 |
IDUs, intravenous drug users; NS, not significant.
a
Infected male gender versus total male gender.
b
Infected Han group versus total Han group.
c
Infected Dai group versus total Dai group.
d
Infected Jingpo group versus total Jingpo group.